GSK Backed By Fed. Circ. In Leukemia Drug Patent Suit
16 April 2013
Intellectual Property partner Lisa Ferri (New York) is quoted on the Federal Circuit decision that ruled GlaxoSmithKline LLC's leukemia drug Arzerra® does not infringe a Biogen Idec Inc. and Genentech Inc. patent covering an antibody therapy.